Estradiol/etonogestrel intravaginal ring - Merck

Drug Profile

Estradiol/etonogestrel intravaginal ring - Merck

Alternative Names: ENG-CVR; ENG-E2; ENG/CVR; Etonogestrel/17β-estradiol; Etonogestrel/estradiol intravaginal ring; MK-8342B; SCH 900432

Latest Information Update: 20 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Merck & Co
  • Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Norpregnanes; Progesterone congeners; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Dysmenorrhoea; Pregnancy

Most Recent Events

  • 28 Feb 2017 Discontinued - Phase-II for Dysmenorrhoea in Germany, Netherlands, Spain, Denmark, Norway (Vaginal) due to business reasons (Merck Annual report 2016)
  • 28 Feb 2017 Discontinued - Phase-III for Dysmenorrhoea in Finland, USA, Sweden, Poland (Vaginal) due to business reasons (Merck Annual report 2016)
  • 28 Feb 2017 Discontinued - Phase-III for Pregnancy (Prevention) in USA, Puerto Rico, Norway, Finland, Netherlands, Germany, Spain, Hungary, Poland, Sweden, Austria, Denmark, Czech Republic (Vaginal) due to business reasons (Merck Annual report 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top